Biologically active secondary metabolites and biotechnological applications of species of the family Chaetomiaceae (Sordariales): an updated review from 2016 to 2021

Fungi are eukaryotic organisms that have the ability to synthesize an enormous number of metabolites with a vast diversity of chemical structures and bioactivities. Chaetomiaceae species are a wealthy source of enzymes with diverse biotechnological and industrial applications such as PMO (polysaccha...

Full description

Saved in:
Bibliographic Details
Published in:Mycological progress 2021-05, Vol.20 (5), p.595-639
Main Authors: Ibrahim, Sabrin R. M., Mohamed, Shaimaa G. A., Sindi, Ikhlas A., Mohamed, Gamal A.
Format: Article
Language:English
Subjects:
Amino acids
Biological activity
Biomedical and Life Sciences
Biotechnology
Chaetomiaceae
Dextranase
Ecology
Enzymes
Industrial applications
Laccase
Lead compounds
Life Sciences
Medicinal plants
Metabolites
Microbiology
Monooxygenase
Peptides
Plant protection
Plant Sciences
Polyketides
Polysaccharides
Proteolysis
Proteolytic enzymes
Review Article
Secondary metabolites
Species
Terpenes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fungi are eukaryotic organisms that have the ability to synthesize an enormous number of metabolites with a vast diversity of chemical structures and bioactivities. Chaetomiaceae species are a wealthy source of enzymes with diverse biotechnological and industrial applications such as PMO (polysaccharide monooxygenase), L-methioninase, β-1,3-glucanase, laccase, dextranase, lipolytic, pectinolytic, amylolytic, chitinolytic, and proteolytic enzymes. Different classes of secondary metabolites have been reported from this family are derived from various biosynthetic pathways such as alkaloids, polyketides, peptides, terpenes, and polyketide-amino acid hybrid secondary metabolites. These metabolites have attracted research interest due to their fascinating structural frameworks and bioactivities. Therefore, these compounds can be taken into account as candidates for the development of effective and novel lead compounds for medicine, as well as for plant protection. The current review represents the relevant information for Chaetomiaceae species, in particular, its new and first reported secondary metabolites and their pharmacological activities, as well as the biotechnological applications published from 2016 until the beginning of 2021.
ISSN:1617-416X
1861-8952
DOI:10.1007/s11557-021-01704-w